This study was a single-case study in the form of A1B1C1A2B2C2 design with multiple baselines and a follow-up of 6 months (Registration Code: TCTR20180605001). Data was collected during January 2015 to December 2016. The patient was a 37-year-old woman with the diagnosis of infiltrating lobular carcinoma (ILC) with metastasis invasion of axillary lymph nodes who was under oncological resection of the right breast with modified radical mastectomy and axillary lymph node dissection of 1st and 2nd level. The patient underwent chemotherapy and doxorubicin (Adriamycin) 60 mg/m2 IV + cyclophosphamide (Cytoxan) 600 mg/m2 every three weeks, as well as a dose of tamoxifen (TMX), 20 mg daily.
Inclusion criteria were: diagnosis of breast cancer (Stage 4) defined by the American joint committee on cancer, completion of chemotherapy or radiotherapy, age above 18 years, diagnosis of dysthymic disorder based on DSM criteria, ability to read and write in completing the study questionnaires and not using any psychiatric drug or receiving psychological interventions in the three months leading up to the study. Exclusion criteria were including: psychiatric disorders such as schizophrenia, auditory tissue injury, or mental retardation that prevents sitting for 40 minutes.
Preliminary evaluation was carried out 28 days prior to the registration of the baseline included an electroencephalograph examination, blood and urine tests by a team consisting of a psychiatrist, two clinical psychologists, and a nurse. Acupuncture was performed twice a week for three weeks (six sessions) and was conducted in the form of sessions of 30 to 45 minutes before lunch. During the session, five ear points called sympathetic, Shen Men, kidney, liver and lungs were interfered. Acupuncture in both ears was performed using one-use stainless steel needles (13 mm + 0.25 mm) with a depth of 2 - 3 mm by a trained physician and acupuncturist with a degree and five-year history of treatment (Second author, K. P.). The MBCT is a combination of MBSR and cognitive-behavioral techniques, including psycho education, exercises and cognitive restructuring, and developing pleasant activities. This treatment was provided to the subject for three weeks (two sessions per week) and each session for two hours.
In baseline A1 and A2 (three weeks, six evaluations), only the evaluation was carried out, and no interventions were made. In phase B1 (three weeks) and B2 (three weeks), acupuncture and mindfulness-based cognitive therapy were presented, respectively. The interval between the two phases of intervention was 6 months and the six-month follow-up (C1 and C2) was done. The entire study period was 15 months and 30 evaluations were carried out. In order to collect data in this study, a structured clinical interview (SCID), researcher-made demographic questionnaire, visual analog scale (VAS) and Beck depression inventory (BDI) were used. All the data of this study were collected after agreement with the patient, and informed consent was received before the intervention and publication, and all stages of the study were based on the latest version of the Helsinki declaration. The data were analyzed using a single case study design model protocol.
The scores of visual analogue scale showed a significant decrease during the three weeks of acupuncture (B1) (P < 0.05), although this reduction was not maintained in the follow-up stage (P > 0.05). But the scores of depression index did not decrease significantly during the three weeks of acupuncture (B1) (P > 0.05).
The scores of visual analogue scale and depression in three weeks of baseline (A
1), three weeks of mindfulness-based cognitive therapy (B
1) and three evaluations in a six-month follow-up (C
1) are presented in
Figures 1 and
2.
Pain index during mindfulness-based cognitive therapy
Depression index during mindfulness-based cognitive therapy
The scores of visual analogue scale decreased significantly during the three weeks of mindfulness-based cognitive therapy (B1) (P < 0.05), although this reduction was not maintained in the follow-up stage (P > 0.05). The scores of depression index decreased significantly during the three weeks of mindfulness-based cognitive therapy (B1) (P < 0.05), although this reduction was not maintained in the follow-up stage (P > 0.05).